The treatment of Anemia & Weight Loss with vitamins

Anemia and Weight Loss: Mitamins custom make quality formulas for the treatment of Anemia & Weight Loss with vitamins. A Anemia & Weight Loss formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Anemia and Weight Loss

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Folate
    800
    mcg
    200%
    Vitamin B12
    1000
    mcg
    16667%
    Iron
    9
    mg
    50%
    Green Tea Extract
    50
    mg
    *
    L-Carnitine
    50
    mg
    *
    L-Glutamine
    50
    mg
    *
  • Amount Per Serving
    % DV
    Yellow Dock Extract
    100
    mg
    *
    Conjugated Linoleic Acid
    50
    mg
    *
    Pyruvate
    50
    mg
    *
    Cayenne Extract
    50
    mg
    *
    Dandelion Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Anemia and Weight Loss Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Geriatric Social Work Shortage Addressed By Hartford Foundation Awards
The Gerontological Society of America (GSA) has received a five year, $5 million renewal grant from the John A. Hartford Foundation of New York, NY to provide financial and career support for 39 doctoral fellows in geriatric social work and awards for 60 pre-dissertation doctoral students.
Remicade(R) Receives EU Approval As First And Only Biologic Treatment For Pediatric Crohn's Disease
Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission has approved a new indication for REMICADE(R) (infliximab) allowing for the treatment of severe, active Crohn's disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy, or who are intolerant to, or have contraindications for, such therapies.
This information concerning the support of Anemia and Weight Loss treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments